10x Genomics, Inc. Debt Securities, Available-for-sale, Amortized Cost
10x Genomics, Inc. (TXG) had Debt Securities, Available-for-sale, Amortized Cost of $223.62 million as of 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Notes
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2022-11-03
- 2022-09-30: Debt Securities, Available-for-sale, Amortized Cost $223.62M.
- 2022-06-30: Debt Securities, Available-for-sale, Amortized Cost $229.28M.
- 2022-03-31: Debt Securities, Available-for-sale, Amortized Cost $229.24M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost |
|---|---|
| 2022-09-30 | $223.62M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $229.28M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $229.24M 10-Q · filed 2022-05-05 |